On June 18th, Jiuzhou Pharma launched its new division specializing in peptide and oligonucleotide drugs under the name "Jiuzhou TIDES.".

The grand ceremony took place at the Bund of Shanghai, "Shanghai Wai Tan," by the Huangpu River, where industry pioneers gathered to witness this pivotal event.

Lirong Hua, Chairman of Jiuzhou Pharma, delivered the welcome speech of the ceremony, emphasizing Jiuzhou's commitment to innovation, continuous development, and sustained cooperation with Jiuzhou's partners. In her speech, Chairman Lirong Hua threw light on Jiuzhou's focus on building cutting-edge technology to provide creative solutions for global drug innovation by importing international expertise.

The event marks an important milestone in Jiuzhou's innovative journey, propelling the company into achieving its goals of providing new high-rank CDMO services. During the ceremony, discussions about industry trends were held, featuring topics of future drug development presented and discussed by specialized academicians.

Professor Lihe Zhang, Academician of CAS and Professor of Peking University, gave a keynote speech on "Oligonucleotide Drug Development and Methods to Implement This Technology in China's Pharma Industry."

Professor Zhen Huang, a distinguished Chinese expert and professor at Sichuan University, gave an academic presentation on "Selenium reshaping oligonucleotide drugs: underlying innovations in oligonucleotide drugs, molecular diagnostics, and structural chemical biology."

On the other hand, Dr. Michael W. Pennington, Head of Peptide and Oligonucleotides CDMO, shared a keynote presentation titled "The Future for Peptide Drugs Looks to be Huge."

On that lovely night and by the Huangpu River, the launch was celebrated by industry leaders, through which Jiuzhou Pharma showed its dedication to customer-centric services and its willingness to collaborate with partners to develop the pharmaceutical industry.

On June 18th, Jiuzhou Pharma launched its new division specializing in peptide and oligonucleotide drugs under the name "Jiuzhou TIDES.".

The grand ceremony took place at the Bund of Shanghai, "Shanghai Wai Tan," by the Huangpu River, where industry pioneers gathered to witness this pivotal event.

Lirong Hua, Chairman of Jiuzhou Pharma, delivered the welcome speech of the ceremony, emphasizing Jiuzhou's commitment to innovation, continuous development, and sustained cooperation with Jiuzhou's partners. In her speech, Chairman Lirong Hua threw light on Jiuzhou's focus on building cutting-edge technology to provide creative solutions for global drug innovation by importing international expertise.

The event marks an important milestone in Jiuzhou's innovative journey, propelling the company into achieving its goals of providing new high-rank CDMO services. During the ceremony, discussions about industry trends were held, featuring topics of future drug development presented and discussed by specialized academicians.

Professor Lihe Zhang, Academician of CAS and Professor of Peking University, gave a keynote speech on "Oligonucleotide Drug Development and Methods to Implement This Technology in China's Pharma Industry."

Professor Zhen Huang, a distinguished Chinese expert and professor at Sichuan University, gave an academic presentation on "Selenium reshaping oligonucleotide drugs: underlying innovations in oligonucleotide drugs, molecular diagnostics, and structural chemical biology."

On the other hand, Dr. Michael W. Pennington, Head of Peptide and Oligonucleotides CDMO, shared a keynote presentation titled "The Future for Peptide Drugs Looks to be Huge."

On that lovely night and by the Huangpu River, the launch was celebrated by industry leaders, through which Jiuzhou Pharma showed its dedication to customer-centric services and its willingness to collaborate with partners to develop the pharmaceutical industry.

On June 18th, Jiuzhou Pharma launched its new division specializing in peptide and oligonucleotide drugs under the name "Jiuzhou TIDES.".

The grand ceremony took place at the Bund of Shanghai, "Shanghai Wai Tan," by the Huangpu River, where industry pioneers gathered to witness this pivotal event.

Lirong Hua, Chairman of Jiuzhou Pharma, delivered the welcome speech of the ceremony, emphasizing Jiuzhou's commitment to innovation, continuous development, and sustained cooperation with Jiuzhou's partners. In her speech, Chairman Lirong Hua threw light on Jiuzhou's focus on building cutting-edge technology to provide creative solutions for global drug innovation by importing international expertise.

The event marks an important milestone in Jiuzhou's innovative journey, propelling the company into achieving its goals of providing new high-rank CDMO services. During the ceremony, discussions about industry trends were held, featuring topics of future drug development presented and discussed by specialized academicians.

Professor Lihe Zhang, Academician of CAS and Professor of Peking University, gave a keynote speech on "Oligonucleotide Drug Development and Methods to Implement This Technology in China's Pharma Industry."

Professor Zhen Huang, a distinguished Chinese expert and professor at Sichuan University, gave an academic presentation on "Selenium reshaping oligonucleotide drugs: underlying innovations in oligonucleotide drugs, molecular diagnostics, and structural chemical biology."

On the other hand, Dr. Michael W. Pennington, Head of Peptide and Oligonucleotides CDMO, shared a keynote presentation titled "The Future for Peptide Drugs Looks to be Huge."

On that lovely night and by the Huangpu River, the launch was celebrated by industry leaders, through which Jiuzhou Pharma showed its dedication to customer-centric services and its willingness to collaborate with partners to develop the pharmaceutical industry.